Decreased FEF50 as an indicator of comorbid asthma and persistent airflow limitation in patients with chronic rhinosinusitis with nasal polyps: A cross-sectional study
机构:[1]Department of Respiratory and Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.首都医科大学附属北京同仁医院首都医科大学附属同仁医院[2]Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.临床科室耳鼻咽喉-头颈外科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[3]Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing 100005, China.研究所耳鼻咽喉科研究所首都医科大学附属北京同仁医院首都医科大学附属同仁医院[4]Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.临床科室变态反应科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[5]Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing 100730, China.
This work was supported by grants from national key Research&Development program of China (No. 2022YFC2504100), the program for the Changjiang scholars and innovative research team (No. IRT13082), the CAMS innovation fund for medical sciences (No. 2019-I2M-5-022), the Capital’s funds for health improvement and research (No. 2022-1-1091), and the Natural Science Cultivation Fund of Beijing Tongren Hospital (No. 2021-YJJ-ZR-014).
第一作者机构:[1]Department of Respiratory and Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
通讯作者:
通讯机构:[1]Department of Respiratory and Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.[2]Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.[3]Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing 100005, China.[4]Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.[5]Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing 100730, China.[*1]Department of Respiratory and Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China[*2]Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
推荐引用方式(GB/T 7714):
Wang Xuechen,Li Fangyuan,Wang Chengshuo,et al.Decreased FEF50 as an indicator of comorbid asthma and persistent airflow limitation in patients with chronic rhinosinusitis with nasal polyps: A cross-sectional study[J].CHINESE MEDICAL JOURNAL.2024,137(3):353-355.doi:10.1097/CM9.0000000000002925.
APA:
Wang Xuechen,Li Fangyuan,Wang Chengshuo,Huang Kai,Shen Shen...&Zhang Luo.(2024).Decreased FEF50 as an indicator of comorbid asthma and persistent airflow limitation in patients with chronic rhinosinusitis with nasal polyps: A cross-sectional study.CHINESE MEDICAL JOURNAL,137,(3)
MLA:
Wang Xuechen,et al."Decreased FEF50 as an indicator of comorbid asthma and persistent airflow limitation in patients with chronic rhinosinusitis with nasal polyps: A cross-sectional study".CHINESE MEDICAL JOURNAL 137..3(2024):353-355